PMID- 19560880 OWN - NLM STAT- MEDLINE DCOM- 20100331 LR - 20220408 IS - 1879-355X (Electronic) IS - 0360-3016 (Linking) VI - 76 IP - 4 DP - 2010 Mar 15 TI - A comparison of volumetric modulated arc therapy and conventional intensity-modulated radiotherapy for frontal and temporal high-grade gliomas. PG - 1177-84 LID - 10.1016/j.ijrobp.2009.03.013 [doi] AB - PURPOSE: Volumetric modulated arc therapy (VMAT), the predecessor to Varian's RapidArc, is a novel extension of intensity-modulated radiotherapy (IMRT) wherein the dose is delivered in a single gantry rotation while the multileaf collimator leaves are in motion. Leaf positions and the weights of field samples along the arc are directly optimized, and a variable dose rate is used. This planning study compared seven-field coplanar IMRT (cIMRT) with VMAT for high-grade gliomas that had planning target volumes (PTVs) overlapping organs at risk (OARs). METHODS AND MATERIALS: 10 previously treated patients were replanned to 60 Gy in 30 fractions with cIMRT and VMAT using the following planning objectives: 98% of PTV covered by 95% isodose without violating OAR and hotspot dose constraints. Mean OAR doses were maximally decreased without reducing PTV coverage or violating hotspot constraints. We compared dose-volume histogram data, monitor units, and treatment times. RESULTS: There was equivalent PTV coverage, homogeneity, and conformality. VMAT significantly reduced maximum and mean retinal, lens, and contralateral optic nerve doses compared with IMRT (p < 0.05). Brainstem, chiasm, and ipsilateral optic nerve doses were similar. For 2-Gy fractions, mean monitor units were as follows: cIMRT = 789 +/- 112 and VMAT = 363 +/- 45 (relative reduction 54%, p = 0.002), and mean treatment times (min) were as follows: cIMRT = 5.1 +/- 0.4 and VMAT = 1.8 +/- 0.1 (relative reduction 65%, p = 0.002). CONCLUSIONS: Compared with cIMRT, VMAT achieved equal or better PTV coverage and OAR sparing while using fewer monitor units and less time to treat high-grade gliomas. CI - Copyright 2010 Elsevier Inc. All rights reserved. FAU - Shaffer, Richard AU - Shaffer R AD - Department of Radiation Oncology, BC Cancer Agency, Vancouver, British Columbia V5Z 4E6, Canada. FAU - Nichol, Alan M AU - Nichol AM FAU - Vollans, Emily AU - Vollans E FAU - Fong, Ming AU - Fong M FAU - Nakano, Sandy AU - Nakano S FAU - Moiseenko, Vitali AU - Moiseenko V FAU - Schmuland, Moira AU - Schmuland M FAU - Ma, Roy AU - Ma R FAU - McKenzie, Michael AU - McKenzie M FAU - Otto, Karl AU - Otto K LA - eng PT - Comparative Study PT - Journal Article PT - Research Support, Non-U.S. Gov't DEP - 20090627 PL - United States TA - Int J Radiat Oncol Biol Phys JT - International journal of radiation oncology, biology, physics JID - 7603616 SB - IM MH - Brain Neoplasms/pathology/*radiotherapy MH - Brain Stem/radiation effects MH - Dose Fractionation, Radiation MH - Female MH - Glioma/pathology/*radiotherapy MH - Humans MH - Lens, Crystalline/radiation effects MH - Male MH - Optic Nerve/radiation effects MH - Radiation Injuries/*prevention & control MH - Radiotherapy, Intensity-Modulated/*methods MH - Retina/radiation effects MH - Tumor Burden EDAT- 2009/06/30 09:00 MHDA- 2010/04/01 06:00 CRDT- 2009/06/30 09:00 PHST- 2008/08/27 00:00 [received] PHST- 2009/03/03 00:00 [revised] PHST- 2009/03/05 00:00 [accepted] PHST- 2009/06/30 09:00 [entrez] PHST- 2009/06/30 09:00 [pubmed] PHST- 2010/04/01 06:00 [medline] AID - S0360-3016(09)00419-2 [pii] AID - 10.1016/j.ijrobp.2009.03.013 [doi] PST - ppublish SO - Int J Radiat Oncol Biol Phys. 2010 Mar 15;76(4):1177-84. doi: 10.1016/j.ijrobp.2009.03.013. Epub 2009 Jun 27.